검색어 : 통합검색[Ashcroft Neil W.]
-
21
-
Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial
-
Bayman, Neil;
Appel, Wiebke;
Ashcroft, Linda;
Baldwin, David R.;
Bates, Andrew;
Darlison, Liz;
Edwards, John G.;
Ezhil, Veni;
Gilligan, David;
Hatton, Matthew;
Jegannathen, Apurna;
Mansy, Talal;
Peake, Michael D.;
Pemberton, Laura;
Rintoul, Robert C.;
Snee, Michael;
Ryder, W. David;
Taylor, Paul;
Faivre-Finn, Corinne;
The Christie National Health Service Foundation Trust, Manchester, United Kingdom;
Lancashire Teaching Hospitals National Health Service Foundation Trust, Preston, United Kingdom;
The Christie National Health Service Foundation Trust, Manchester, United Kingdom;
Nottingham University Hospitals National Health Service Trust, Nottingham, United Kingdom;
University Hospital Southampton National Health Service Foundation Trust, Southampton, United Kingdom;
University Hospitals of Leicester National Health Service Trust, Leicester, United Kingdom;
Sheffield Teaching Hospitals National Health Service Foundation Trust, Sheffield, United Kingdom;
Royal Surrey County Hospital, National Health Service Foundation Trust, Guildford, United Kingdom;
Cambridge University Hospital National Health Service Foundation Trust, Cambridge, United Kingdom;
Sheffield Teaching Hospitals National Health Service Foundation Trust, Sheffield, United Kingdom;
University Hospitals of North Midlands National;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.37,
2019,
pp.1200-1208)
-
22
-
Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis
-
Bowes, John;
Ashcroft, James;
Dand, Nick;
Jalali-najafabadi, Farideh;
Bellou, Eftychia;
Ho, Pauline;
Marzo-Ortega, Helena;
Helliwell, Philip S;
Feletar, Marie;
Ryan, Anthony W;
Kane, David J;
Korendowych, Eleanor;
Simpson, Michael A;
Packham, Jonathan;
McManus, Ross;
Brown, Matthew A;
Smith, Catherine H;
Barker, Jonathan N;
McHugh, Neil;
FitzGerald, Oliver;
Warren, Richard B;
Barton, Anne;
Arthritis Research UK Centre for Genetics and Genomics , Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester , Manchester , UK;
Arthritis Research UK Centre for Genetics and Genomics , Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester , Manchester , UK;
Division of Genetics and Molecular Medicine , King’s College London, Guy’s Hospital , London , UK;
Arthritis Research UK Centre for Genetics and Genomics , Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester , Manchester , UK;
Arthritis Research UK Centre for Genetics and Genomics , Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester , Manchester , UK;
Arthritis Research UK Centre for Genetics and Genomic;
(Annals of the rheumatic diseases : the official journal,
v.76,
2017,
pp.1774-1779)
-
23
-
A kinase-dead <i>Csf1r</i> mutation associated with adult-onset leukoencephalopathy has a dominant inhibitory impact on CSF1R signalling
-
Stables, Jennifer;
Green, Emma K.;
Sehgal, Anuj;
Patkar, Omkar L.;
Keshvari, Sahar;
Taylor, Isis;
Ashcroft, Maisie E.;
Grabert, Kathleen;
Wollscheid-Lengeling, Evi;
Szymkowiak, Stefan;
McColl, Barry W.;
Adamson, Antony;
Humphreys, Neil E.;
Mueller, Werner;
Starobova, Hana;
Vetter, Irina;
Shabestari, Sepideh Kiani;
Blurton-Jones, Matthew M.;
Summers, Kim M.;
Irvine, Katharine M.;
Pridans, Clare;
Hume, David A.;
Mater Research Institute-University of Queensland, Translational Research Institute , Brisbane, Qld 4102 , Australia;
Centre for Inflammation Research and Simons Initiative for the Developing Brain, University of Edinburgh , Edinburgh EH16 4TJ , UK;
Mater Research Institute-University of Queensland, Translational Research Institute , Brisbane, Qld 4102 , Australia;
Mater Research Institute-University of Queensland, Translational Research Institute , Brisbane, Qld 4102 , Australia;
Mater Research Institute-University of Queensland, Translational Research Institute , Brisbane, Qld 4102 , Australia;
Mater Research Institute-University of Queensland, Translational Research Institute , Brisbane, Qld 4102 , Australia;
Centre for Inflammation Research and Simons Initiative for the Developing Brain, University of Edin;
(Development,
v.149,
2022,
pp.dev200237)
-
24
-
Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance <i>in vivo</i>
-
Dobson, Claire L.;
Devine, Paul W. A.;
Phillips, Jonathan J.;
Higazi, Daniel R.;
Lloyd, Christopher;
Popovic, Bojana;
Arnold, Joanne;
Buchanan, Andrew;
Lewis, Arthur;
Goodman, Joanne;
van der Walle, Christopher F.;
Thornton, Peter;
Vinall, Lisa;
Lowne, David;
Aagaard, Anna;
Olsson, Lise-Lotte;
Ridderstad Wollberg, Anna;
Welsh, Fraser;
Karamanos, Theodoros K.;
Pashley, Clare L.;
Iadanza, Matthew G.;
Ranson, Neil A.;
Ashcroft, Alison E.;
Kippen, Alistair D.;
Vaughan, Tristan J.;
Radford, Sheena E.;
Lowe, David C.;
MedImmune Ltd, Granta Park , Cambridge, CB21 6GH, UK;
Astbury Centre for Structural Molecular Biology, University of Leeds , Leeds, LS2 9JT, UK;
Department of Chemical Engineering and Biotechnology, University of Cambridge , Cambridge, CB2 3RA, UK;
MedImmune Ltd, Granta Park , Cambridge, CB21 6GH, UK;
MedImmune Ltd, Granta Park , Cambridge, CB21 6GH, UK;
MedImmune Ltd, Granta Park , Cambridge, CB21 6GH, UK;
MedImmune Ltd, Granta Park , Cambridge, CB21 6GH, UK;
MedImmune Ltd, Granta Park , Cambridge, CB21 6GH, UK;
MedImmune Ltd, Granta Park , Cambridge, CB21 6GH, UK;
MedImmune Ltd, Granta Park , Cambridge, CB21 6GH, UK;
MedImmune Ltd, Granta Park , Cambridge, CB21 6GH, UK;
MedImmune Ltd, Granta Park , Cambridge, CB21 6GH, UK
-
25
-
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy
-
Booth, Stephen;
Curley, Helen M.;
Varnai, Csilla;
Arnold, Roland;
Lee, Lennard Y. W.;
Campton, Naomi A.;
Cook, Gordon;
Purshouse, Karin;
Aries, James;
Innes, Andrew;
Cook, Lucy B.;
Tomkins, Oliver;
Oram, Helen S.;
Tilby, Michael;
Kulasekararaj, Austin;
Wrench, David;
Dolly, Saoirse;
Newsom‐
Davies, Tom;
Pettengell, Ruth;
Gault, Abigail;
Moody, Sam;
Mittal, Sajjan;
Altohami, Mohammed;
Tillet, Tania;
Illingworth, Jack;
Mukherjee, Leena;
Apperly, Jane;
Ashcroft, John;
Rabin, Neil;
Carmichael, Jonathan;
Cazier, Jean‐
Baptiste;
Kerr, Rachel;
Middleton, Gary;
Collins, Graham P.;
Palles, Claire;
Oxford NIHR Biomedical Research Centre, Department of Haematology, Churchill Hospital, Oxford, ;
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, ;
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, ;
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, ;
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, ;
Institute of Trans;
(British journal of haematology,
v.196,
2022,
pp.892-901)